Written and maintained by CASRAI Editorial Board
Published
On this page
Short answer
Enamel remineralisation is the physicochemical redeposition of calcium and phosphate ions into demineralised enamel to rebuild crystal lattice density. Driven by chemical supersaturation, the process arrests early non-cavitated carious lesions. Fluoride catalyses this deposition, converting hydroxyapatite into acid-resistant fluorapatite and reducing the dissolution threshold from pH 5.5 to pH 4.5.
Definition and scope
Dental enamel is an acellular hard tissue composed of 96% inorganic carbonated hydroxyapatite crystals and 4% water and organic matrix. Because ameloblasts undergo programmed apoptosis upon tooth eruption, mature enamel lacks cellular remodeling mechanisms. Enamel conservation relies entirely on extracellular physicochemical redeposition termed enamel remineralisation.
The clinical scope applies strictly to non-cavitated incipient lesions (white-spot lesions) and surface softening from dietary acid exposure. These early lesions retain a pseudo-intact surface zone (10–30 μm thick) covering a porous lesion body. As long as the crystallite framework remains intact, mineral ions diffuse inward to rebuild mineral density. Once surface cavitation occurs, chemical remineralisation cannot re-establish anatomical contours, requiring restorative intervention.
How it works or how it is used in practice
Enamel remineralisation is governed by the ion activity product (IAP) of surrounding fluids relative to the solubility product (Ksp) of calcium phosphate minerals:
Ca10(PO4)6(OH)2 ⇌ 10 Ca2+ + 6 PO43− + 2 OH−
Saliva and laboratory media act as natural buffer solutions maintaining supersaturation of calcium and phosphate. When bacterial fermentation generates organic acids, local pH drops below the hydroxyapatite critical threshold (~5.5), protonating phosphate ions and causing mineral dissolution. Raising pH restores supersaturation, driving mineral precipitation back into the enamel lattice.
Therapeutic systems operate through three documented mechanisms:
- Fluorapatite Transformation: Fluoride ions substitute for hydroxyl groups, yielding fluorapatite:
Ca10(PO4)6(OH)2 + 2 F− → Ca10(PO4)6F2 + 2 OH−
Fluorapatite features higher chemical stability and a lower critical dissolution pH of ~4.5. - Subsurface Diffusion vs Surface Arrest: High-concentration topical fluorides can induce rapid hyper-mineralisation in the outer 30 μm zone, sealing surface pores. Biomimetic carriers ensure sustained ion diffusion into deep lesion bodies (100–150 μm).
- Biomimetic Nucleation: Rational peptides, such as self-assembling peptide P11-4, assemble into 3D β-sheet networks inside lesion pores to nucleate de novo apatite crystallites.
Types or related concepts
Remineralisation agents used in oral health laboratories and clinical formularies are classified by active chemistry, delivery pathway, and lesion penetration depth:
| Class / Agent | Primary Chemistry | Mechanism | Lesion Depth Profile | Reference |
|---|---|---|---|---|
| Topical Fluorides (NaF, APF) | Sodium fluoride / Acidulated phosphate | Supplies F− to form fluorapatite; surface CaF2 reservoir | High superficial (0–30 μm); lower deep recovery (100–150 μm) | Biomimetics (PMC13510187) |
| CPP-ACP (Recaldent) | Casein phosphopeptide-stabilised ACP | Stabilises bioavailable Ca2+ and PO4(3−); prevents early precipitation | Deep diffusion across subsurface pores (100–150 μm) | Cureus (PMC13645188) |
| Bioactive Glass (45S5) | Calcium sodium phosphosilicate | Aqueous ion exchange raises pH; silica gel nucleates apatite | Moderate subsurface; high surface buffering | BMC Oral Health (PMC13651250) |
| Nano-Hydroxyapatite (nHAp) | Synthetic rod-shaped nanoparticles (~20–50 nm) | Direct crystallite templating and pore adsorption | High recovery across 30 μm and 100–150 μm depths | Biomimetics (PMC13510187) |
| Self-Assembling Peptides (P11-4) | 11-amino-acid synthetic peptide | pH-triggered β-sheet hydrogel nucleates de novo apatite | Deep diffusion before in situ assembly | Cureus (PMC13645188) |
| Silver Diamine Fluoride (SDF 38%) | Silver fluoride in ammonia [Ag(NH3)2F] | Antimicrobial silver deposition paired with fluorapatite synthesis | Arrests surface and lesion body; oxidises dark | Front Oral Health (PMC8757692) |
Where it matters for labs, clinics or supply decisions
Remineralisation kinetics directly inform laboratory experimental designs and clinical preventive supply evaluations:
- In Vitro pH-Cycling Protocols: Experimental caries simulations prepare synthetic remineralising solutions with phosphate buffers maintaining precise Ca/P ratios (1.67) and neutral pH. Controlled supersaturation avoids premature precipitation artifacts during benchtop trials.
- Analytical Metrology in Cariology: Laboratories quantify mineral recovery through cross-sectional microhardness across standard depths (30, 50, 100, 150 μm). Lesion pore volumes are visualised with polarized optical microscopy, while crystallite prism orientation is characterised using scanning electron microscopy.
- Formulary and Storage Stability: Soluble calcium and phosphate salts readily precipitate insoluble phosphates in liquid storage. Clinical procurement teams verify that preventive formulations incorporate bioavailable stabilizing technologies to preserve ionic activity.
- Synergy with Cavity Liners: In deep cavitated preparations where pulp protection is required, materials such as calcium hydroxide liners stimulate dentin bridge formation, whereas non-cavitated margins depend on topical remineralisation therapies.
Common misunderstandings
Several common misconceptions affect research interpretations and clinical recommendations:
- Misunderstanding: Remineralisation can reverse cavitated lesions.
Fact: Remineralisation restores mineral into intact crystal scaffolds. Once physical cavitation occurs, structural loss cannot be repaired by mineral precipitation, requiring restorative filling materials. - Misunderstanding: Higher fluoride concentration always improves deep lesion remineralisation.
Fact: Excessively high fluoride concentrations can cause rapid superficial hyper-mineralisation, sealing surface pores and blocking ion diffusion into deep lesion bodies (100–150 μm). Sustained low-dose fluoride or biomimetic carriers provide more uniform depth profiles. - Misunderstanding: Enamel heals via cellular regeneration.
Fact: Enamel contains no viable cells, collagen, or blood supply. Remineralisation is entirely an extracellular physicochemical precipitation process governed by local thermodynamics. - Misunderstanding: Fluoride makes teeth immune to acid dissolution.
Fact: Fluorapatite lowers the critical dissolution pH to ~4.5, conferring superior acid resistance compared to hydroxyapatite (~5.5). However, strong acidic exposure below pH 4.0 will still dissolve fluorapatite.
Frequently Asked Questions
What is the critical pH of dental enamel?
The critical pH of unmodified hydroxyapatite enamel is approximately 5.5. Below this threshold, oral fluid becomes undersaturated and demineralisation occurs. Fluorapatite has a lower critical pH of ~4.5, providing greater resistance to acid challenge.
How does saliva facilitate natural remineralisation?
Saliva provides a continuous reservoir of bioavailable calcium and phosphate ions while salivary bicarbonate buffers bacterial acids, returning oral fluid above the critical pH threshold to favour mineral redeposition.
Can nano-hydroxyapatite replace fluoride in remineralisation?
Nano-hydroxyapatite deposits directly into surface micropores and subsurface lesions, achieving mineral recovery comparable to fluoride in laboratory assays. However, it does not form fluorapatite, so the repaired mineral maintains a critical dissolution pH of ~5.5 unless combined with fluoride.
How do cariology laboratories measure remineralisation?
Laboratories quantify remineralisation using cross-sectional microhardness across depths from 30 to 150 μm, transverse microradiography (determining mineral loss parameter ΔZ), and surface electron microscopy to assess crystal morphology.
Sources
- National Center for Biotechnology Information. (2026). Biomimetic Enamel Remineralization in Pediatric Dentistry: From Biological Principles to Clinical Evidence. Cureus, 18(10): e71284. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13645188/ (Accessed November 11, 2026).
- National Center for Biotechnology Information. (2026). Biomimetic Strategies for Subsurface Enamel Remineralization: Depth-Dependent Effects of Biomimetic Agents Compared with Fluoride. Biomimetics, 11(4): 208. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13510187/ (Accessed November 11, 2026).
- National Center for Biotechnology Information. (2026). Effect of a 45S5 bioactive glass-containing gel on the remineralization of artificial caries-like lesions in primary teeth: an in vitro study. BMC Oral Health, 26: 412. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13651250/ (Accessed November 11, 2026).
- National Center for Biotechnology Information. (2021). Evidence-Based Caries Management for All Ages-Practical Guidelines. Frontiers in Oral Health, 2: 709702. URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8757692/ (Accessed November 11, 2026).
